Skip to content

Abstract 6058: Absolute versus Relative Low-Density Lipoprotein Cholesterol Lowering and Long-Term Cardiovascular Outcomes in Patients with Diabetes After Acute Myocardial Infarction

Nov 2026 · Circulation · 0 citations

Abstract

Background: Current guidelines recommend that very-high-risk patients with diabetes after acute myocardial infarction (AMI) achieve both an absolute low-density lipoprotein cholesterol (LDL-C) goal of <55 mg/dL and a reduction of ≥50% from baseline. However, in routine practice, many patients fail to achieve both targets, and it remains unclear whether the absolute LDL-C level or the magnitude of LDL-C reduction is more closely related to clinical outcomes. Hypothesis: We hypothesized that relative LDL-C reduction would be more strongly associated with major adverse cardiovascular events (MACE) than attainment of the absolute LDL-C target. Methods: We analyzed 1,449 patients with diabetes and AMI from the prospective Korea Acute Myocardial Infarction Registry-National Institutes of Health (KAMIR-NIH). Patients were categorized according to time-averaged LDL-C (TA-LDL-C) level (<55 mg/dL, n=343; ≥55 mg/dL, n=1,106) and, separately, according to the percentage reduction in TA-LDL-C from admission (≥50%, n=323; <50%, n=1,126). The primary endpoint was MACE, defined as the composite of cardiovascular death, myocardial infarction, or ischemic stroke. Individual components were assessed as secondary endpoints. Cumulative incidence was estimated by Kaplan-Meier analysis and compared using the log-rank test. Results: Over a mean follow-up of approximately 4.6 years, MACE occurred in 152 patients (10.5%). The 5-year cumulative incidence of MACE did not differ between patients with TA-LDL-C <55 mg/dL and those with TA-LDL-C ≥55 mg/dL (10.4% vs 10.5%; log-rank p=0.931; Figure, panel A). In contrast, patients with a TA-LDL-C reduction ≥50% had a significantly lower 5-year cumulative incidence of MACE than those with a reduction <50% (7.2% vs 11.6%; log-rank p=0.024; Figure, panel A). For the individual components, neither lipid metric showed a statistically significant association. However, cardiovascular death tended to be less frequent in the lower TA-LDL-C group and the greater-reduction group (TA-LDL-C <55 vs ≥55 mg/dL, p=0.073; TA-LDL-C reduction ≥50% vs <50%, p=0.201; Figure, panel B). Myocardial infarction showed a similar trend, particularly according to TA-LDL-C reduction (p=0.217 and p=0.096, respectively; Figure, panel C). Ischemic stroke incidence did not differ between groups (p=0.173 and p=0.211; Figure, panel D). Conclusions: In patients with diabetes after AMI, a TA-LDL-C reduction of ≥50% was associated with lower long-term MACE incidence, whereas achievement of TA-LDL-C <55 mg/dL was not. These findings suggest that the magnitude of LDL-C reduction may provide prognostic information beyond the absolute on-treatment LDL-C level in this population.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.